Forecasting in vivo pharmacokinetics of metformin HCl floating beads using Gastroplus® PBPK
Open Access
- 28 January 2025
- journal article
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 140
Abstract
Background Diabetes mellitus type II is expected to impact large number of population worldwide. Among the available theraputic options, Metformin hydrochloride is a key medication, particularly for those who cannot effectively manage the condition through changes in diet and lifestyle alone. This research aimed to formulate floating Metformin HCl beads and developed a physiological based pharmacokinetic (PBPK) model by using Gastroplus® software to predict their in vivo parameters from in vitro release study. Methods Sodium alginate-based MH floating beads were prepared by dissolving different concentrations of sodium alginate in deionized water, incorporating MH (1 g) and calcium carbonate (1.5 mg) as a gas-forming agent, and mixing at 200 rpm. The air-free dispersion, achieved through 30 minutes of sonication, was dropped into a 5% w/v calcium chloride solution containing 5% v/v isopropyl alcohol via a syringe for cross-linking and bead formation. Beads were cured in the solution for 30 minutes to enhance mechanical strength, then filtered, washed, and air-dried for 24 hours, ensuring uniformity and stability for controlled drug delivery and the prepared beads wereevaluated for their entrapment efficiency %, morphology, floating property and in vitro releasUltimately, using Gastroplus® software, to predict the pharmacokinetic profile of in vitro release results. Results Entrapment efficiency exhibited acceptable values and the beads were smooth rounded in shape for all formulations. The beads remained afloat during the release study; the release study revealed that F1 to F5 showed asymptotic slow-release, while F6 and F7 gave shorter release times. The prediction of absorption indicated highest MH absorption was in jejunum, then duodenum. Conclusion The prepared Beads had promising pharmacokinetic parameters and C max was close to MH modified released tablet.Keywords
This publication has 31 references indexed in Scilit:
- Gastroretentive core–shell hydrogel assembly for sustained release of metformin hydrochlorideEuropean Polymer Journal, 2022
- In vitro and in vivo evaluation of gastro-retentive carvedilol loaded chitosan beads using Gastroplus™International Journal of Biological Macromolecules, 2017
- Mechanistic understanding of the effect of renal impairment on metformin oral absorption using computer simulationsJournal of Pharmaceutical Investigation, 2017
- Calcium alginate hydrogel beads with high stiffness and extended dissolution behaviourEuropean Polymer Journal, 2016
- Systematic Review of the Benefits and Risks of Metformin in Treating Obesity in Children Aged 18 Years and YoungerJAMA Pediatrics, 2014
- Morphology and Property of Calcium Silicate Encapsulated with Alginate BeadsSilicon, 2013
- Size and Shape of Calcium Alginate Beads Produced by Extrusion DrippingChemical Engineering & Technology, 2013
- Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H+-organic cation antiportersBiochemical Pharmacology, 2007
- Biowaiver extension potential to BCS Class III high solubility-low permeability drugs: bridging evidence for metformin immediate-release tabletEuropean Journal of Pharmaceutical Sciences, 2004
- Pharmacokinetics of metformin after intravenous and oral administration to manEuropean Journal of Clinical Pharmacology, 1979